Research Spotlight
Bimuno GOS and its effect on hyperpnoea-induced bronchoconstriction and markers of airway inflammation
Hyperpnoea-induced bronchoconstriction (HIB) describes the transient narrowing of the airways following hyperpnoea which affects more than half of individuals with asthma (Needham, 2020). Importantly, HIB is closely related to exercise-induced bronchoconstriction (EIB) which can affect up to 54% of athletes, regardless as to whether they experience asthma (Koya et al., 2020). Providing relief for these individuals is key to supporting athlete wellbeing and for reducing the impact on sports performance. In this Research Spotlight, we explore the effect of Bimuno GOS on HIB in a cohort of individuals with asthma and how this may translate from the perspective of sport (Williams et al., 2016).
Learn More
Exploring the use of Bimuno® GOS on traveller’s diarrhoea
Traveller’s diarrhoea (TD) is the most common cause of gastrointestinal (GI) issues encountered by those travelling in high-risk geographical areas (NICE., 2023). Whilst the prevalence of TD is dependent on the season of travel and destination, it is thought to affect up to 70% of traveller’s, particularly those visiting low or middle-income countries (NICE., 2023). Given the infectious nature of TD, modulation of the gut microbiome with prebiotics is an area of interest. In this Research Spotlight, we look at the effect of Bimuno® GOS on TD in healthy adults (Drakoularakou et al., 2010; Hasle et al., 2017).
Learn More
The effects of Bimuno® GOS on athlete digestive health and immunity in a cohort of elite rugby union players
Elite rugby players endure high training loads that can lead to frequent upper respiratory and gastrointestinal issues. A recent study by Parker et al. (2023) investigated the impact of Bimuno® GOS, a prebiotic, on these health concerns. Explore the full details of the study on this article.
